Literature DB >> 16411420

Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis.

Adriana M W van Marion, Johannes J A Auwerda, Monique C Minnema, Rolinda van Oosterom, Jelle Adelmeijer, Philip G de Groot, Frank W G Leebeek, Pieter Sonneveld, Henk M Lokhorst, Ton Lisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16411420     DOI： 10.1160/th05-06-1341

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

Review 1.  Thrombosis in multiple myeloma (MM).

Authors:  Gabriela Cesarman-Maus; Esteban Braggio; Rafael Fonseca
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

Review 2.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

3.  The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.

Authors:  Waqas Rehman; Lisa M Arfons; Hillard M Lazarus
Journal:  Ther Adv Hematol       Date:  2011-10

4.  Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Sigurdur Y Kristinsson; Thomas R Fears; Gloria Gridley; Ingemar Turesson; Ulf-Henrik Mellqvist; Magnus Björkholm; Ola Landgren
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

5.  Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.

Authors:  David C Johnson; Sophie Corthals; Christine Ramos; Antje Hoering; Kim Cocks; Nicholas J Dickens; Jeff Haessler; Harmut Goldschmidt; J Anthony Child; Sue E Bell; Graham Jackson; Dalsu Baris; S Vincent Rajkumar; Faith E Davies; Brian G M Durie; John Crowley; Pieter Sonneveld; Brian Van Ness; Gareth J Morgan
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

6.  Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis.

Authors:  Shuang-Qing Liu; Jian-Ying Guo; Jun Du; Qun Deng; Zhong-Jie He; Hong-Yuan Lin; Shu-Hong Lei
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

7.  Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study.

Authors:  Emilie Chalayer; Brigitte Tardy-Poncet; Lionel Karlin; Céline Chapelle; Aurélie Montmartin; Michèle Piot; Denis Guyotat; Philippe Collet; Thomas Lecompte; Bernard Tardy
Journal:  Res Pract Thromb Haemost       Date:  2018-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.